Navigation Links
Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation
Date:2/7/2008

RADNOR, Pa., Feb. 7 /PRNewswire/ -- The following release was issued today jointly by Schiffrin Barroway Topaz & Kessler, LLP and Milberg Weiss LLP:

UNITED STATES DISTRICT COURT

DISTRICT OF MARYLAND

(NORTHERN DIVISION)

IN RE MARTEK BIOSCIENCES CORP. (Ticker: MATK) SECURITIES LITIGATION

Civil Action No. MJG 05-1224

SUMMARY NOTICE OF PROPOSED SETTLEMENT AND SETTLEMENT HEARING

TO: ALL PERSONS AND ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED MARTEK BIOSCIENCES CORPORATION COMMON STOCK DURING THE PERIOD DECEMBER 9, 2004, THROUGH APRIL 28, 2005, INCLUSIVE.

YOU ARE HEREBY NOTIFIED that the above-captioned action has been certified as a class action and that a settlement for Six Million Dollars ($6,000,000) has been proposed. A hearing will be held before the Honorable Marvin J. Garbis in the United States District Court for the District of Maryland, United States Courthouse, 101 W. Lombard Street, Baltimore, MD 21201, at 10:00 a.m., on April 4, 2008, to determine whether (1) the proposed Settlement should be approved by the Court as fair, reasonable, and adequate; (2) Plaintiffs' Co-Lead Counsel's application for an award of attorneys' fees and reimbursement of expenses should be approved; (3) Lead Plaintiffs should be reimbursed for their reasonable costs and expenses (including lost wages) directly related to their representation of the Class in the litigation; and (4) the claims against the Defendants should be dismissed with prejudice.

IF YOU ARE A MEMBER OF THE CLASS DESCRIBED ABOVE, YOUR RIGHTS WILL BE AFFECTED AND YOU MAY BE ENTITLED TO SHARE IN THE SETTLEMENT FUND. If you have not yet received the full printed Notice of Proposed Settlement of Class Action and Motion for Attorneys' Fees and Expenses (the "Settlement Notice") and Proof of Claim and Release form ("Claim Form"), you may obtain copies of these documents by visiting MartekSecuritiesSettlement.com or by contacting:

Martek Biosciences Corp. Securities Litigation

Claims Administrator

c/o A.B. Data, Ltd.

Post Office Box 170500

Milwaukee, WI 53217

(866) 963-9978

Inquiries, other than requests for copies of the Settlement Notice and Claim Form, may be made to Plaintiffs' Co-Lead Counsel:

Katharine M. Ryan, Esq.

Schiffrin Barroway Topaz & Kessler, LLP

280 King of Prussia Road

Radnor, PA 19087

Janine L. Pollack, Esq.

Todd S. Kussin, Esq.

Milberg Weiss LLP

One Pennsylvania Plaza

New York, NY 10119

To participate in the Settlement, you must submit a Claim Form no later than May 15, 2008. If you are a member of the Class and do not submit a proper Claim Form, you will not share in the Settlement but you nevertheless will be bound by the Final Judgment and Order of Dismissal of the Court. As more fully described in the Settlement Notice, the deadline for submitting objections and requests for exclusion is March 21, 2008.

Further information may also be obtained by directing your inquiry in writing to the Claims Administrator, A.B. Data, Ltd., at the address listed above or call toll free (866) 963-9978.

By Order of The Court


'/>"/>
SOURCE Schiffrin Barroway Topaz & Kessler, LLP
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Delay in Start of VNUS Patent Litigation and Court Ruling on Summary Judgment Motion
2. Summary Notice of Class Action in Re McKesson HBOC, Inc. Securities Litigation
3. Par Pharmaceutical Provides Summary of Analyst/Investor Day
4. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
5. Putting the Medical Profession on Notice!: Widow Tells Tragic Story of How Her Husband Died Due to Misdiagnosis and Mistreatment
6. Melanomas may appear noticeably different than other moles
7. Medifast Receives Notice Regarding NYSE Listing
8. ULURU Inc. Announces Issuance of Notice of Allowance for Nanoparticle Aggregate Patent
9. Innocoll Receives Intends to Grant Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology
10. Mediware Information Systems, Inc. Receives Notice from the Nasdaq Stock Market
11. Vermillion, Inc. Announces Receipt of Notice of Noncompliance From Nasdaq
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... TherapySites, the leading website ... Tennessee Counseling Association. This new relationship allows TherapySites to continue to ... adding exclusive benefits and promotional offers. , "TCA is extremely excited about this ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating ... many ways they remain in the eye of the beholder, according to experts who ... of The American Journal of Managed Care. For the full issue, click here ...
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
Breaking Medicine Technology: